Abstract
Despite the success of 99mTc-sestamibi and 99mTc-tetrofosmin, the search for 99mTc heart imaging agents having a pharmacokinetic behavior much closer to that of an ideal perfusion tracer has been never interrupted. This short review illustrates advances in this field that have been made using the class of 99mTc complexes characterized by the presence of a terminal technetium-nitrogen multiple bond. This category of 99mTc compounds has proven to be particularly useful for cardiac imaging and a number of highly interesting compounds have been developed. The main chemical and biological properties of these agents are briefly summarized here.
Keywords: Myocardial imaging, Myocardial perfusion, 99mTc nitrido complexes, SPECT
Current Radiopharmaceuticals
Title: The Missed Tc-99m Radiopharmaceuticals for Cardiac Imaging
Volume: 2 Issue: 4
Author(s): Adriano Duatti, Shuang Liu and Roberto Pasqualini
Affiliation:
Keywords: Myocardial imaging, Myocardial perfusion, 99mTc nitrido complexes, SPECT
Abstract: Despite the success of 99mTc-sestamibi and 99mTc-tetrofosmin, the search for 99mTc heart imaging agents having a pharmacokinetic behavior much closer to that of an ideal perfusion tracer has been never interrupted. This short review illustrates advances in this field that have been made using the class of 99mTc complexes characterized by the presence of a terminal technetium-nitrogen multiple bond. This category of 99mTc compounds has proven to be particularly useful for cardiac imaging and a number of highly interesting compounds have been developed. The main chemical and biological properties of these agents are briefly summarized here.
Export Options
About this article
Cite this article as:
Duatti Adriano, Liu Shuang and Pasqualini Roberto, The Missed Tc-99m Radiopharmaceuticals for Cardiac Imaging, Current Radiopharmaceuticals 2009; 2 (4) . https://dx.doi.org/10.2174/1874471010902040268
DOI https://dx.doi.org/10.2174/1874471010902040268 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Long Chain Omega-3 Polyunsaturated Fatty Acids in Pediatric Metabolic Syndrome
Mini-Reviews in Medicinal Chemistry Evidence for the Involvement of Resistin in Inflammation and Cardiovascular Disease
Current Diabetes Reviews Are the Pleiotropic Effects of Telmisartan Clinically Relevant?
Current Pharmaceutical Design Recommendations for Severe Hypertriglyceridemia Treatment, are there New Strategies?
Current Vascular Pharmacology Comprehensive Review on Diabetes Associated Cardiovascular Complications - The Vitamin D Perspective
Cardiovascular & Hematological Disorders-Drug Targets The Therapeutic Potential of Hepatocyte Growth Factor for Myocardial Infarction and Heart Failure
Current Pharmaceutical Design Pomegranate Consumption and Blood Pressure: A Review
Current Pharmaceutical Design Psychosocial Risk Factors Related to Ischemic Heart Disease in Women
Current Pharmaceutical Design Opportunities and Challenges for Host-Directed Therapies in Tuberculosis
Current Pharmaceutical Design Ivabradine: The Hope for a Good Treatment of Ischemic Heart Disease
Current Medicinal Chemistry New Therapies in Cystic Fibrosis
Current Pharmaceutical Design Nucleic Acid Drugs for Preventing Restenosis after Coronary Revascularization
Current Topics in Medicinal Chemistry Pathophysiology of Platelet Resistance to Anti-Aggregating Agents in Insulin Resistance and Type 2 Diabetes: Implications for Anti-Aggregating Therapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Evaluation of Endothelial (dys)Function, Left Ventricular Structure and Function in Patients with Chronic Kidney Disease
Current Vascular Pharmacology Insulin Resistance and Polycystic Ovary Syndrome Through Life
Current Pharmaceutical Design Dietary Fish Oil Concentrates Associated Health Benefits: A Recent Development of Cardiovascular Risk Reduction
Current Pharmaceutical Design Challenges and Perspectives of Antiplatelet Therapy in Patients with Diabetes Mellitus and Coronary Artery Disease
Current Pharmaceutical Design Epinephrine and its Role in the Development of Obesity and Hypertension
Current Hypertension Reviews Pros and Cons of Aggressive Blood Pressure Lowering in Patients with Type 2 Diabetes
Current Vascular Pharmacology Adenosine Deaminase in the Modulation of Immune System and its Potential as a Novel Target for Treatment of Inflammatory Disorders
Current Drug Targets